Spots Global Cancer Trial Database for thyroid dysfunction
Every month we try and update this database with for thyroid dysfunction cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Thyroid Dysfunction and Nivolumab Reponse in NSCLC | NCT04470440 | Non Small Cell ... Treatment Adver... Thyroid Dysfunc... Immune Checkpoi... Prognosis | 18 Years - | University Hospital, Brest | ||
Thyroid Dysfunction and Nivolumab Reponse in NSCLC | NCT04470440 | Non Small Cell ... Treatment Adver... Thyroid Dysfunc... Immune Checkpoi... Prognosis | 18 Years - | University Hospital, Brest | ||
Study of Euthyroid Hypothyroxinemia in Metastatic Breast Carcinoma | NCT03787303 | Metastatic Brea... Thyroid Dysfunc... | Triiodothyronin... | 18 Years - 105 Years | Aultman Health Foundation | |
Study of Euthyroid Hypothyroxinemia in Metastatic Breast Carcinoma | NCT03787303 | Metastatic Brea... Thyroid Dysfunc... | Triiodothyronin... | 18 Years - 105 Years | Aultman Health Foundation |